Top endocrinology stories: ADA updates its Standards of Care, mindfulness-based eating may improve weight loss

This past week, the top story in endocrinology was a report on the new American Diabetes Association, or ADA, 2019 Standards of Medical Care in Diabetes which included several new and revised clinical practice recommendations designed to put the patient at the center of care.

The second most-read story was a study that found that mindfulness-based eating strategies may increase 6-month weight loss.

Other popular stories included a Healio exclusive emphasizing how educators must address weight reduction in diabetes management, research findings that vaginal estrogen is not associated with increased risks for CVD or cancer and data showing that a single injection combination of basal insulin glargine and lixisenatide is safe and effective for older adults with type 2 diabetes. – by Alaina Tedesco

ADA emphasizes patient-centered approach in updated Standards of Care

The American Diabetes Association 2019 Standards of Medical Care in Diabetes includes several new and revised clinical practice recommendations designed to put the patient at the center of care, including efforts to reduce therapeutic inertia, utilize person-centered language and expanded recommendations for children and adolescents with type 2 diabetes. Read more.

Mindfulness-based eating strategies may increase 6-month weight loss

Adults with obesity who attended group sessions teaching mindfulness-based eating techniques lost an average of 2.85 kg more than similar adults who attended group classes without mindful eating strategies, according to findings published in The Journal of Clinical Endocrinology & Metabolism. Read more.

Educators must address weight reduction in diabetes management

Many adults with diabetes also have overweight or obesity. Although the mechanisms underlying the connection between diabetes and adiposity are not fully understood, experts point to insulin resistance induced by excess weight as the cause of elevated blood glucose levels. Moreover, type 2 diabetes and overweight and obesity share common etiologies, including environment, genetics, and physiological and social factors. Read more.

Vaginal estrogen not associated with increased risks for CVD, cancer

Postmenopausal women who reported use of vaginal estrogen were not at increased risks for developing cardiovascular disease, cancer or hip fracture over 18 years vs. similar women who did not report taking vaginal estrogen, according to an analysis of the Nurses’ Health Study. Read more.

Insulin glargine, lixisenatide combination safe, effective for older adults with type 2 diabetes

A single injection combination of basal insulin glargine and lixisenatide known as iGlarLixi improved glycemic control without increasing the risk for severe hypoglycemia in older adults with type 2 diabetes, according to findings published in the Journal of Diabetes and its Complications. Read more.